1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of outcomes associated with the use of newly approved oncology drugs in medicare beneficiaries
    Journal Article

    Green, A. K.; Curry, M.; Trivedi, N.; Bach, P. B.; Mailankody, S.
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Erasing iatrogenic neoantigens from in vivo CRISPR screens
    Editorial

    Yi, F.; Klebanoff, C. A.
    Immunity (2021)

    Fulltext@MSK | Save
  • An unconventional view of T cell reconstitution after allogeneic hematopoietic cell transplantation
    Review

    Andrlová, H.; van den Brink, M. R. M.; Markey, K. A.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save
  • RNA based approaches to profile oncogenic pathways from low quantity samples to drive precision oncology strategies
    Journal Article

    van de Stolpe, A.; Verhaegh, W.; Blay, J. Y.; Ma, C. X.; Pauwels, P.; Pegram, M.; Prenen, H.; De Ruysscher, D.; Saba, N. F.; Slovin, S. F.; more...
    Frontiers in Genetics (2021)

    Fulltext@MSK | Save
  • Zanubrutinib (BGB-3111), a second-generation selective covalent inhibitor of Bruton’s tyrosine kinase and its utility in treating chronic lymphocytic leukemia
    Review

    Rhodes, J. M.; Mato, A. R.
    Drug Design Development and Therapy (2021)

    Fulltext@MSK | Save
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project
    Journal Article

    Shustov, A.; Cabrera, M. E.; Civallero, M.; Bellei, M.; Ko, Y. H.; Manni, M.; Skrypets, T.; Horwitz, S. M.; de Souza, C. A.; Radford, J. A.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: A multicenter observational study
    Journal Article

    Khan, N.; Lindner, S.; Gomes, A. L. C.; Devlin, S. M.; Shah, G. L.; Sung, A. D.; Sauter, C. S.; Landau, H. J.; Dahi, P. B.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Managing older adults with Ph-negative ALL: What is new? Recent advances in treating older adults with ALL
    Review

    Park, J. H.
    Best Practice and Research: Clinical Haematology (2021)

    Fulltext@MSK | Save
  • PD-1 blockade for untreated Hodgkin lymphoma
    Editorial

    Moskowitz, A. J.
    Blood (2021)

    Fulltext@MSK | Save